• People

    Advanced Search

  • Services
  • All Services

  • Back to News & Media
    Blog

    Your Simple Guide to Depo-Provera Lawsuits and Settlements

     Download as PDF

    What is a meningioma and what types of injuries qualify?

    Depo-Provera has many known side effects. However, the current Depo-Provera litigation mainly involves a “signature injury” that was not properly warned against by the Depo-Provera drugmaker, Pfizer. That signature injury is cranial meningioma.

    Meningiomas are tumors that have been shown by scientific studies to be caused by Depo-Provera. While meningiomas can form in the tissues surrounding the spinal cord, the signature injury for the purposes of the current litigation are meningiomas that formed in the tissues surrounding the brain – cranial meningiomas. Depending on the size and aggressiveness of the cranial meningioma, symptoms can include pain, altered vision, hearing loss, cognitive impairment, and seizures.

    Cranial meningiomas must be diagnosed through computed tomography (CT) scan or magnetic resonance imaging (MRI). Once diagnosed, cranial meningioma sufferers frequently undergo chemotherapy, radiation treatment and surgery.

    Bottom Line: You should have been diagnosed with a cranial (not just spinal) meningioma to qualify for the current Depo-Provera litigation.

    How do I prove I used Depo-Provera?

    The current Depo-Provera litigation involves a minimum level of usage, which is typically one year. Depo-Provera is injected every three months, so the minimum level of usage would equal four injections.

    The United States Food and Drug Administration (FDA) approved Depo-Provera for sale back in 1992, and a related drug, Depo-SubQ Provera, was approved shortly afterward. This means that some treatment records could be decades old and may be difficult to obtain.

    In those situations, claimants (mostly through their attorneys) will have to search for and try to obtain archived medical records. These searches will not just consist of the usual pharmacy records, but include physician’s records (as injections were many times administered in a doctor’s office) and insurance records (which can tend to be preserved for longer periods of time). Even if these searches eventually prove fruitless, a claimant wants to be in a position to affirm that all avenues were exhausted and ask the Court to rely upon a claimant’s affidavit or similar form of proof.

    Bottom Line: You should be able to prove that you used Depo-Provera for one year (received four shots) to qualify for the current Depo-Provera litigation.

    What is the current Depo-Provera litigation?

    All of the federal Depo-Provera lawsuits have been consolidated into a multidistrict litigation (MDL) before Judge M. Casey Rogers in the Northern District of Florida. It is expected that the MDL will eventually consist of five to ten thousand claims.

    Each of the claims in the MDL will retain their individual identities (this is not a class action), but are being consolidated for uniform pretrial proceedings and a what should be a handful of “bellwether cases.” Bellwether cases are basically test cases that are worked up for trial and primarily used to set the value of any future settlements.

    Bottom Line: Most cases are being consolidated in the MDL in Florida.

    How do I find a Depo-Provera attorney?

    You have been diagnosed with a cranial meningioma after using Depo-Provera for at least one year and your claim will likely be filed in the MDL. You now need to talk to legal counsel with experience in MDL litigations and Depo-Provera claims.

    Do your homework and research the firm you will be working with — there is a really good chance it will not be the same lawyer that handled your last speeding ticket, or the people answering the phone at the other end of one of the 800 numbers that flash across your television screen late at night.

    Also, as with any claims, Pfizer will assert many defenses in the MDL. Some of these defenses can include applicable filing deadlines like statutes of limitations and repose. This basically means that the longer a claimant waits to file a lawsuit, the more likely these types of defenses could be used against that claimant.

    Bottom Line: Speak to experienced legal counsel as soon as you can.

    Since you are already reading our law firm’s blog, please feel free to look us up or check us out on Facebook and Twitter. Established in 1933, we are a firm of over ninety experienced attorneys. We handle MDL litigations throughout the nation.

    Call us anytime, at no obligation to you, at 609.895.7369, to talk about your claims, your options, and what to expect going forward.

    Key Contacts

    Martin P. Schrama
    609.895.7261

    Firm Highlights

    Stark & Stark Shareholder Deborah S. Dunn, Esq. Installed as 2nd Vice President and Diversity Officer of the New Jersey Association for Justice for 2026–2027

    Stark & Stark is proud to announce that Shareholder Deborah S. Dunn, Esq. has been installed as 2nd Vice President and Diversity Officer of the...

    Stark & Stark Recognized with Community Partner Award by Mercer County Community College Foundation

    Stark & Stark is proud to announce that the firm has been recognized with the Community Partner Award by the Mercer County Community College...

    Carin A. O’Donnell, Esq. Inducted as 2026-2027 President of the Pennsylvania Association for Justice

    Stark & Stark is proud to announce that Carin A. O'Donnell, Esq. was sworn in as the 2026-2027 President of the Pennsylvania Association for...

    Stark & Stark’s Thomas S. Onder, Esq. Receives 2026 ICSC Trustees’ Distinguished Service Award

    Stark & Stark is proud to announce that Thomas S. Onder, Esq., Shareholder and Chair of the Firm’s Shopping Center & Retail Development...

    Stark & Stark’s Joseph H. Lemkin Esq., Named 2026 Professional Lawyer of the Year for the Jewish Bar Association of New Jersey

    Stark & Stark is proud to announce that Joseph H. Lemkin Esq. has been selected by the New Jersey Commission on Professionalism in the Law as...

    Our Values Remain: A Message on the Closing of Diversity Lab

    Stark & Stark is saddened and disappointed to learn that Diversity Lab, the organization that created and manages the Mansfield Certification...

    Congratulations to Shareholder Bhaveen R. Jani, Esq. on his Installation as Treasurer of the Middlesex County Bar Foundation

    Stark & Stark is proud to announce that Shareholder Bhaveen R. Jani, Esq. has been installed as Treasurer of the Middlesex County Bar Foundation,...

    Denise Mariani, Esq., and Jonathan Lauri, Esq. Secure $750,000 Jury Verdict Against Hamilton Healthcare and Rehabilitation Center

    It is our pleasure to announce that Denise Mariani, Esq., and Jonathan Lauri, Esq., secured a $750,000 jury verdict on behalf of a nursing home...

    Stark & Stark Welcomes 2026 Summer Law Clerks

    Stark & Stark is proud to announce its 10th Annual Summer Law Clerk Program. Five Summer Law Clerks will join the firm from June through July...

    Retail Development Team Secures Major Recovery for Landlord Client Amid Bankruptcy Dispute

    Our Shopping Center and Retail Development Group recently secured a multi-million-dollar settlement for a commercial landlord client' s property...

    Jeffrey A. Krawitz, Esq. and Catherine Foley, Esq. Secure $950,000 Settlement in Surgical Malpractice Matter

    Jeffrey A. Krawitz, Esq. and Catherine Foley, Esq. recently secured a confidential $950,000 settlement in a surgical malpractice case. “This...

    Victoria Wilton, Esq. Selected to Serve on New Jersey State Bar Association Family Law Executive Committee

    We are proud to announce that Victoria Wilton, Esq. has been selected to serve on the New Jersey State Bar Association Family Law Executive Committee...